Click Here for 5% Off Your First Aladdin Purchase!

Asapiprant - 98%, high purity , CAS No.932372-01-5, Antagonist of DP 1 receptor

  • Moligand™
  • ≥98%
Item Number
A412177
Grouped product items
SKUSizeAvailabilityPrice Qty
A412177-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$119.90
A412177-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$350.90
A412177-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$503.90
A412177-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$814.90
A412177-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,120.90
View related series
DP1 receptor Antagonist

Basic Description

SynonymsAsapiprant|932372-01-5|Asapiprant [INN]|BGE-175|BGE175|B2LW71CRGL|S-555739|2-(5-(4-((4-isopropoxyphenyl)sulfonyl)piperazin-1-yl)-2-(oxazol-2-yl)phenoxy)acetic acid|2-(2-(Oxazol-2-yl)-5-(4-(4-((propan-2-yl)oxy)benzenesulfonyl(piperazin-1-yl)phenoxy)acetic
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsAsapiprant (S-555739) is a potent and selective antagonist for DP1 receptor with Ki of 0.44 nM.
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of DP 1 receptor
Product Description

Information

Asapiprant (S-555739) is a potent and selective antagonist for DP1 receptor with Ki of 0.44 nM.

Product Properties

ALogP3.1

Associated Targets

PTGER2 Tclin Prostaglandin E2 receptor EP2 subtype 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGDR Tclin Prostaglandin D2 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGER4 Tclin Prostaglandin E2 receptor EP4 subtype 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGER1 Tclin Prostaglandin E2 receptor EP1 subtype 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGFR Tclin Prostaglandin F2-alpha receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGIR Tclin Prostacyclin receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGER3 Tclin Prostaglandin E2 receptor EP3 subtype 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TBXA2R Tclin Thromboxane A2 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-[2-(1,3-oxazol-2-yl)-5-[4-(4-propan-2-yloxyphenyl)sulfonylpiperazin-1-yl]phenoxy]acetic acid
INCHI InChI=1S/C24H27N3O7S/c1-17(2)34-19-4-6-20(7-5-19)35(30,31)27-12-10-26(11-13-27)18-3-8-21(24-25-9-14-32-24)22(15-18)33-16-23(28)29/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,28,29)
InChi Key ZMZNWNTZRWXTJU-UHFFFAOYSA-N
Canonical SMILES CC(C)OC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C3=CC(=C(C=C3)C4=NC=CO4)OCC(=O)O
Isomeric SMILES CC(C)OC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C3=CC(=C(C=C3)C4=NC=CO4)OCC(=O)O
Alternate CAS 932372-01-5
PubChem CID 59232326
MeSH Entry Terms 2-(2-(oxazol-2-yl)-5-(4-(4-((propan-2-yl)oxy)benzenesulfonyl(piperazin-1-yl)phenoxy)acetic acid;asapiprant;BGE 175;BGE-175;S-555739
Molecular Weight 501.55

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

10 results found

Lot NumberCertificate TypeDateItem
B2426437Certificate of AnalysisJan 17, 2024 A412177
B2426438Certificate of AnalysisJan 17, 2024 A412177
B2426439Certificate of AnalysisJan 17, 2024 A412177
B2426440Certificate of AnalysisJan 17, 2024 A412177
B2426441Certificate of AnalysisJan 17, 2024 A412177
B2426442Certificate of AnalysisJan 17, 2024 A412177
B2426443Certificate of AnalysisJan 17, 2024 A412177
B2426444Certificate of AnalysisJan 17, 2024 A412177
B2426445Certificate of AnalysisJan 17, 2024 A412177
B2426446Certificate of AnalysisJan 17, 2024 A412177

Related Documents

References

1. Takahashi G, Asanuma F, Suzuki N, Hattori M, Sakamoto S, Kugimiya A, Tomita Y, Kuwajima G, Abraham WM, Deguchi M et al..  (2015)  Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma..  Eur J Pharmacol,  765  (3): (15-23).  [PMID:26277322]
2. Wong LR, Zheng J, Wilhelmsen K, Li K, Ortiz ME, Schnicker NJ, Thurman A, Pezzulo AA, Szachowicz PJ, Li P et al..  (2022)  Eicosanoid signaling blockade protects middle-aged mice from severe COVID-19..  Nature,  129  (3): (589-97).  [PMID:35314834]

Solution Calculators